Literature DB >> 26123836

The Case for Universal Testing of Colorectal Tumors for Microsatellite Instability: A Coming Mismatch Between Clinical and Laboratory Testing.

Patrick M Lynch1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26123836     DOI： 10.1007/s10620-015-3739-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for?

Authors:  Fay Kastrinos; Sapna Syngal
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

2.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Authors:  Noralane M Lindor; Lawrence J Burgart; Olga Leontovich; Richard M Goldberg; Julie M Cunningham; Daniel J Sargent; Catherine Walsh-Vockley; Gloria M Petersen; Michael D Walsh; Barbara A Leggett; Joanne P Young; Melissa A Barker; Jeremy R Jass; John Hopper; Steve Gallinger; Bharati Bapat; Mark Redston; Stephen N Thibodeau
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

3.  Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

Authors:  D Williams Parsons; Angshumoy Roy; Sharon E Plon; Sameek Roychowdhury; Arul M Chinnaiyan
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

4.  Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.

Authors:  Arjen R Mensenkamp; Ingrid P Vogelaar; Wendy A G van Zelst-Stams; Monique Goossens; Hicham Ouchene; Sandra J B Hendriks-Cornelissen; Michael P Kwint; Nicoline Hoogerbrugge; Iris D Nagtegaal; Marjolijn J L Ligtenberg
Journal:  Gastroenterology       Date:  2013-12-10       Impact factor: 22.682

5.  Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.

Authors:  Trilokesh D Kidambi; Amie Blanco; Megan Myers; Peggy Conrad; Kate Loranger; Jonathan P Terdiman
Journal:  Dig Dis Sci       Date:  2014-06-06       Impact factor: 3.199

6.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Hidewaki Nakagawa; Kaisa Sotamaa; Thomas W Prior; Judith Westman; Jenny Panescu; Dan Fix; Janet Lockman; Ilene Comeras; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

7.  Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.

Authors:  Laura C Beamer; Marcia L Grant; Carin R Espenschied; Kathleen R Blazer; Heather L Hampel; Jeffrey N Weitzel; Deborah J MacDonald
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

8.  Differentiating Lynch-like from Lynch syndrome.

Authors:  John M Carethers
Journal:  Gastroenterology       Date:  2014-01-24       Impact factor: 22.682

9.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Authors:  Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

Review 10.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Authors:  Glenn E Palomaki; Monica R McClain; Stephanie Melillo; Heather L Hampel; Stephen N Thibodeau
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.